Hisashi Yanagida
Research Subjects
Hisashi Yanagida has a total of 4 co-authors. Here are the top co-authors by number of shared publications:
Hidenori Takahashi
Pain Center, Department of Anesthesiology, Teikyo University School of Medicine, Ichihara Hospital, Ichihara City, Chiba, Japan
1 shared publicationMiyuki Miyazaki
1 shared publicationShigeho Morita
1 shared publicationTakashi Nanbu
1 shared publication
Latest Publications
- 1 January 1998
- Published by Wolters Kluwer Health in Pain
- Vol. 75 (2) , 391-394
The NMDA-receptor antagonist ketamine abolishes neuropathic pain after epidural administration in a clinical case
A 14-year-old male patient developed severe right limb pain after traumatic sciatic nerve injury. His pain was diagnosed as neuropathic pain (complex regional pain syndrome, type II). He did not respond to any conventional therapy for limb pain including non-steroidal antiinflammatory drugs, antidepressants, anticonvulsants, continuous epidural administration of local anesthetics and psychotherapy. Following continuous epidural administration of a very low dose of ketamine, an N-methyl-D-aspartic acid (NMDA) receptor antagonist, 25 microg/kg per h for 10 days, complete pain relief was obtained without any side-effects. There has been no recurrence of pain for 8 months after discontinuation of epidural ketamine. The symptoms related to dysfunction of the sympathetic nervous system still remained after complete pain relief. We discuss pain mechanisms, pain relief and the use of ketamine in this case.
- 1 January 1998
- Published by Wolters Kluwer Health in Pain
- Vol. 75 (2) , 391-394
The NMDA-receptor antagonist ketamine abolishes neuropathic pain after epidural administration in a clinical case
A 14-year-old male patient developed severe right limb pain after traumatic sciatic nerve injury. His pain was diagnosed as neuropathic pain (complex regional pain syndrome, type II). He did not respond to any conventional therapy for limb pain including non-steroidal antiinflammatory drugs, antidepressants, anticonvulsants, continuous epidural administration of local anesthetics and psychotherapy. Following continuous epidural administration of a very low dose of ketamine, an N-methyl-D-aspartic acid (NMDA) receptor antagonist, 25 microg/kg per h for 10 days, complete pain relief was obtained without any side-effects. There has been no recurrence of pain for 8 months after discontinuation of epidural ketamine. The symptoms related to dysfunction of the sympathetic nervous system still remained after complete pain relief. We discuss pain mechanisms, pain relief and the use of ketamine in this case.